Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)
Hong Kong
· Delayed Price · Currency is HKD 0.600
0.00 (0.00%)
Mar 12, 2025, 4:08 PM HKT
HKG:0460 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 1,755 | 1,861 | 2,181 | 3,038 | 2,464 | 2,878 | Upgrade
|
| Revenue Growth (YoY) | -11.25% | -14.70% | -28.21% | 23.30% | -14.39% | -1.34% | Upgrade
|
| Cost of Revenue | 598.1 | 564.9 | 693.61 | 607.9 | 549.78 | 588.99 | Upgrade
|
| Gross Profit | 1,156 | 1,296 | 1,488 | 2,430 | 1,914 | 2,289 | Upgrade
|
| Selling, General & Admin | 940.37 | 911.22 | 1,023 | 1,129 | 858.58 | 716.95 | Upgrade
|
| Research & Development | 479.21 | 577.66 | 936.58 | 868.07 | 729.16 | 598.95 | Upgrade
|
| Other Operating Expenses | -66.75 | -52.69 | 63.72 | -242.74 | -159.1 | -421.11 | Upgrade
|
| Operating Expenses | 1,353 | 1,436 | 2,024 | 1,754 | 1,429 | 894.79 | Upgrade
|
| Operating Income | -196.4 | -140.54 | -536.05 | 676.2 | 485.82 | 1,395 | Upgrade
|
| Interest Expense | -268.26 | -269.34 | -211.18 | -117.35 | -8.22 | -4.71 | Upgrade
|
| Interest & Investment Income | 144.3 | 147.91 | 146.79 | 163.95 | 135.73 | 169.71 | Upgrade
|
| Earnings From Equity Investments | -3.81 | -53.62 | -80.88 | -158.58 | -13.06 | -12.02 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.74 | -6.76 | -18.39 | -4.57 | 7.27 | 19.63 | Upgrade
|
| EBT Excluding Unusual Items | -325.9 | -322.35 | -699.7 | 559.64 | 607.54 | 1,567 | Upgrade
|
| Impairment of Goodwill | - | - | -8.76 | - | - | -2,844 | Upgrade
|
| Gain (Loss) on Sale of Investments | 159.48 | 153.02 | -279.36 | 8.44 | 83.17 | -110.12 | Upgrade
|
| Gain (Loss) on Sale of Assets | 19 | 8.07 | 194.09 | 59.23 | 72.31 | - | Upgrade
|
| Asset Writedown | - | - | -1,329 | -131.3 | - | -1,036 | Upgrade
|
| Other Unusual Items | - | - | - | - | 2.83 | - | Upgrade
|
| Pretax Income | -147.42 | -161.26 | -2,123 | 496.01 | 765.84 | -2,423 | Upgrade
|
| Income Tax Expense | 59.29 | 96.43 | 196.79 | 253.12 | 219.04 | 290.39 | Upgrade
|
| Earnings From Continuing Operations | -206.71 | -257.69 | -2,320 | 242.89 | 546.8 | -2,713 | Upgrade
|
| Earnings From Discontinued Operations | - | - | 36.3 | -10.12 | -34.92 | -43.97 | Upgrade
|
| Net Income to Company | -206.71 | -257.69 | -2,283 | 232.77 | 511.89 | -2,757 | Upgrade
|
| Minority Interest in Earnings | 168.91 | 203.67 | 368.36 | 183.74 | -38.51 | 3.98 | Upgrade
|
| Net Income | -37.8 | -54.02 | -1,915 | 416.51 | 473.38 | -2,753 | Upgrade
|
| Net Income to Common | -37.8 | -54.02 | -1,915 | 416.51 | 473.38 | -2,753 | Upgrade
|
| Net Income Growth | - | - | - | -12.01% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 9,281 | 9,297 | 9,330 | 9,431 | 9,466 | 9,468 | Upgrade
|
| Shares Outstanding (Diluted) | 9,281 | 9,297 | 9,330 | 9,483 | 9,466 | 9,468 | Upgrade
|
| Shares Change (YoY) | -0.48% | -0.35% | -1.62% | 0.19% | -0.03% | -0.03% | Upgrade
|
| EPS (Basic) | -0.00 | -0.01 | -0.21 | 0.04 | 0.05 | -0.29 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.01 | -0.21 | 0.04 | 0.05 | -0.29 | Upgrade
|
| EPS Growth | - | - | - | -12.20% | - | - | Upgrade
|
| Free Cash Flow | 107.73 | 74.14 | -355.97 | 64.28 | -279.51 | 917.07 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | 0.01 | -0.04 | 0.01 | -0.03 | 0.10 | Upgrade
|
| Dividend Per Share | 0.019 | - | 0.033 | 0.013 | 0.014 | 0.017 | Upgrade
|
| Dividend Growth | -41.54% | - | 153.85% | -7.14% | -17.65% | 0% | Upgrade
|
| Gross Margin | 65.91% | 69.64% | 68.20% | 79.99% | 77.69% | 79.54% | Upgrade
|
| Operating Margin | -11.19% | -7.55% | -24.58% | 22.26% | 19.71% | 48.45% | Upgrade
|
| Profit Margin | -2.15% | -2.90% | -87.79% | 13.71% | 19.21% | -95.66% | Upgrade
|
| Free Cash Flow Margin | 6.14% | 3.98% | -16.32% | 2.12% | -11.34% | 31.86% | Upgrade
|
| EBITDA | -14.89 | 40.21 | -229.26 | 931.69 | 714.06 | 1,629 | Upgrade
|
| EBITDA Margin | -0.85% | 2.16% | -10.51% | 30.66% | 28.98% | 56.60% | Upgrade
|
| D&A For EBITDA | 181.52 | 180.75 | 306.79 | 255.49 | 228.25 | 234.48 | Upgrade
|
| EBIT | -196.4 | -140.54 | -536.05 | 676.2 | 485.82 | 1,395 | Upgrade
|
| EBIT Margin | -11.19% | -7.55% | -24.58% | 22.26% | 19.71% | 48.45% | Upgrade
|
| Effective Tax Rate | - | - | - | 51.03% | 28.60% | - | Upgrade
|
| Advertising Expenses | - | - | - | - | - | 14.74 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.